CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle

Circulation Research

Volumn 122, Issue 1, 2018, Pages 88-96

  Zhu, Wuqiang ^a   Zhao, Meng ^a,b   Mattapally, Saidulu ^a   Chen, Sifeng ^b   Zhang, Jianyi ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b FUDAN UNIVERSITY   (China)

Author keywords

cell cycle; cyclin D2; induced pluripotent stem cells; myocardial infarction; regeneration

Indexed keywords

CYCLIN D2; LENTIVIRUS VECTOR; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; CCND2 PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CELL ACTIVATION; CELL COUNT; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GRAFT SIZE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MUSCLE; HEART MUSCLE INJURY; HUMAN; HUMAN CELL; INDUCED PLURIPOTENT STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; STEM CELL TRANSPLANTATION; THERAPY EFFECT; ANIMAL; BIOSYNTHESIS; CARDIAC MUSCLE; CELL CULTURE; GENE EXPRESSION; GENETICS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE; HEK293 CELL LINE; INJURIES; METABOLISM; PATHOLOGY; PHYSIOLOGY; REGENERATION; TRANSPLANTATION;

ANIMALS; CELLS, CULTURED; CYCLIN D2; GENE EXPRESSION; HEART VENTRICLES; HEK293 CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOCYTES, CARDIAC; REGENERATION;

EID: 85040175911     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.117.311504     Document Type: Article

References (40)

1. Zhu W, Hassink RJ, Rubart M, Field LJ. Cell-cycle-based strategies to drive myocardial repair. Pediatr Cardiol. 2009;30:710-715. doi: 10.1007/ s00246-009-9408-3.
2. Chen IY, Matsa E, Wu JC. Induced pluripotent stem cells: at the heart of cardiovascular precision medicine. Nat Rev Cardiol. 2016;13:333-349. doi: 10.1038/nrcardio.2016.36.
3. Lafamme MA, Murry CE. Heart regeneration. Nature. 2011;473:326-335. doi: 10.1038/nature10147.
4. Golpanian S, Wolf A, Hatzistergos KE, Hare JM. Rebuilding the damaged heart: mesenchymal stem cells, cell-based therapy, and engineered heart tissue. Physiol Rev. 2016;96:1127-1168. doi: 10.1152/ physrev.00019.2015.
5. Sanganalmath SK, Bolli R. Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res. 2013;113:810-834. doi: 10.1161/CIRCRESAHA.113.300219.
6. Marbán E. Breakthroughs in cell therapy for heart disease: focus on cardiosphere-derived cells. Mayo Clin Proc. 2014;89:850-858. doi: 10.1016/j.mayocp.2014.02.014.
7. Ye L, Chang YH, Xiong Q, et al. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell. 2014;15:750-761. doi: 10.1016/j. stem.2014.11.009.
8. Ong SG, Huber BC, Lee WH, Kodo K, Ebert AD, Ma Y, Nguyen PK, Diecke S, Chen WY, Wu JC. Microfuidic single-cell analysis of transplanted human induced pluripotent stem cell-derived cardiomyocytes after acute myocardial infarction. Circulation. 2015;132:762-771. doi: 10.1161/CIRCULATIONAHA.114.015231.
9. Song K, Nam YJ, Luo X, Qi X, Tan W, Huang GN, Acharya A, Smith CL, Tallquist MD, Neilson EG, Hill JA, Bassel-Duby R, Olson EN. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature. 2012;485:599-604. doi: 10.1038/nature11139.
10. Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L, Conway SJ, Fu JD, Srivastava D. In vivo reprogramming of murine cardiac fbroblasts into induced cardiomyocytes. Nature. 2012;485:593-598. doi: 10.1038/ nature11044.
11. Rajasingh J, Lambers E, Hamada H, Bord E, Thorne T, Goukassian I, Krishnamurthy P, Rosen KM, Ahluwalia D, Zhu Y, Qin G, Losordo DW, Kishore R. Cell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fbroblasts for functional and anatomical ischemic tissue repair. Circ Res. 2008;102:e107-e117. doi: 10.1161/CIRCRESAHA.108.176115.
12. Soonpaa MH, Koh GY, Klug MG, Field LJ. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science. 1994;264:98-101.
13. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 1998;4:929-933.
14. Zeng L, Hu Q, Wang X, et al. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation. 2007;115:1866-1875. doi: 10.1161/CIRCULATIONAHA.106.659730.
15. Li Z, Lee A, Huang M, Chun H, Chung J, Chu P, Hoyt G, Yang P, Rosenberg J, Robbins RC, Wu JC. Imaging survival and function of transplanted cardiac resident stem cells. J Am Coll Cardiol. 2009;53:1229-1240. doi: 10.1016/j.jacc.2008.12.036.
16. Nguyen PK, Riegler J, Wu JC. Stem cell imaging: from bench to bedside. Cell Stem Cell. 2014;14:431-444. doi: 10.1016/j.stem.2014.03.009.
17. Pasumarthi KB, Nakajima H, Nakajima HO, Soonpaa MH, Field LJ. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res. 2005;96:110-118. doi: 10.1161/01.RES.0000152326.91223.4F.
18. Zaruba MM, Zhu W, Soonpaa MH, Reuter S, Franz WM, Field LJ. Granulocyte colony-stimulating factor treatment plus dipeptidylpeptidase-IV inhibition augments myocardial regeneration in mice expressing cyclin D2 in adult cardiomyocytes. Eur Heart J. 2012;33:129-137. doi: 10.1093/ eurheartj/ehr302.
19. Hassink RJ, Pasumarthi KB, Nakajima H, Rubart M, Soonpaa MH, de la Rivière AB, Doevendans PA, Field LJ. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc Res. 2008;78:18-25. doi: 10.1093/cvr/cvm101.
20. Xiong Q, Ye L, Zhang P, Lepley M, Tian J, Li J, Zhang L, Swingen C, Vaughan JT, Kaufman DS, Zhang J. Functional consequences of human induced pluripotent stem cell therapy: myocardial AT P turnover rate in the in vivo swine heart with postinfarction remodeling. Circulation. 2013;127:997-1008. doi: 10.1161/CIRCULATIONAHA.112.000641.
21. Zhang L, Guo J, Zhang P, Xiong Q, Wu SC, Xia L, Roy SS, Tolar J, O'Connell TD, Kyba M, Liao K, Zhang J. Derivation and high engraft-ment of patient-specifc cardiomyocyte sheet using induced pluripo-tent stem cells generated from adult cardiac fbroblast. Circ Heart Fail. 2015;8:156-166. doi: 10.1161/CIRCHEARTFAILURE.114.001317.
22. Zhu W, Gao L, Zhang J. Pluripotent stem cell derived cardiac cells for myocardial repair. J Vis Exp. 2017;120:e55142. doi: 10.3791/55142.
23. Gao L, Kupfer ME, Jung JP, Yang L, Zhang P, Da Sie Y, Tran Q, Ajeti V, Freeman BT, Fast VG, Campagnola PJ, Ogle BM, Zhang J. Myocardial tissue engineering with cells derived from human-induced pluripotent stem cells and a native-like, high-resolution, 3-dimensionally printed scaffold. Circ Res. 2017;120:1318-1325. doi: 10.1161/CIRCRESAHA.116.310277.
24. Sun N, Lee A, Wu JC. Long term non-invasive imaging of embryonic stem cells using reporter genes. Nat Protoc. 2009;4:1192-1201. doi: 10.1038/ nprot.2009.100.
25. Nakamura Y, Wang X, Xu C, Asakura A, Yoshiyama M, From AH, Zhang J. Xenotransplantation of long-term-cultured swine bone marrow-derived mesenchymal stem cells. Stem Cells. 2007;25:612-620. doi: 10.1634/ stemcells.2006-0168.
26. Soonpaa MH, Rubart M, Field LJ. Challenges measuring cardiomyocyte renewal. Biochim Biophys Acta. 2013;1833:799-803. doi: 10.1016/j. bbamcr.2012.10.029.
27. Leone M, Magadum A, Engel FB. Cardiomyocyte proliferation in cardiac development and regeneration: a guide to methodologies and interpretations. Am J Physiol Heart Circ Physiol. 2015;309:H1237-H1250. doi: 10.1152/ajpheart.00559.2015.
28. Wei K, Serpooshan V, Hurtado C, et al. Epicardial FSTL1 reconstitution regenerates the adult mammalian heart. Nature. 2015;525:479-485. doi: 10.1038/nature15372.
29. Engel FB, Schebesta M, Duong MT, Lu G, Ren S, Madwed JB, Jiang H, Wang Y, Keating MT. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev. 2005;19:1175-1187. doi: 10.1101/gad.1306705.
30. Bersell K, Arab S, Haring B, Kühn B. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell. 2009;138:257-270. doi: 10.1016/j.cell.2009.04.060.
31. Bergmann O, Zdunek S, Felker A, et al. Dynamics of cell generation and turnover in the human heart. Cell. 2015;161:1566-1575. doi: 10.1016/j. cell.2015.05.026.
32. Li F, Wang X, Capasso JM, Gerdes AM. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol. 1996;28:1737-1746. doi: 10.1006/ jmcc.1996.0163.
33. Oh H, Taffet GE, Youker KA, Entman ML, Overbeek PA, Michael LH, Schneider MD. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc Natl Acad Sci USA. 2001;98:10308-10313. doi: 10.1073/pnas.191169098.
34. Busk PK, Bartkova J, Strøm CC, Wulf-Andersen L, Hinrichsen R, Christoffersen TE, Latella L, Bartek J, Haunsø S, Sheikh SP. Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro. Cardiovasc Res. 2002;56:64-75.
35. Field LJ. Modulation of the cardiomyocyte cell cycle in genetically altered animals. Ann N Y Acad Sci. 2004;1015:160-170. doi: 10.1196/ annals.1302.013.
36. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ. Paracrine action accounts for marked protection of ischemic heart by Akt-modifed mesenchymal stem cells. Nat Med. 2005;11:367-368. doi: 10.1038/nm0405-367.
37. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ. Mesenchymal stem cells modifed with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med. 2003;9:1195-1201. doi: 10.1038/nm912.
38. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA, Kamp TJ. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res. 2009;104:e30-e41. doi: 10.1161/ CIRCRESAHA.108.192237.
39. Funakoshi S, Miki K, Takaki T, Okubo C, Hatani T, Chonabayashi K, Nishikawa M, Takei I, Oishi A, Narita M, Hoshijima M, Kimura T, Yamanaka S, Yoshida Y. Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyo-cytes. Sci Rep. 2016;6:19111. doi: 10.1038/srep19111.
40. Nakatsu T, Ichiyama S, Hiratake J, Saldanha A, Kobashi N, Sakata K, Kato H. Structural basis for the spectral difference in luciferase biolumi-nescence. Nature. 2006;440:372-376. doi: 10.1038/nature04542.